Both in Pharmaceuticals
Palvella Therapeutics vs Septerna
Over the past year PVLA returned +103.7% and SEPN returned +94.5%; their daily moves had a correlation of 0.37.
PVLA +103.7% SEPN +94.5%Growth of $1, one year, split-adjusted
| Metric | PVLA | SEPN |
|---|---|---|
| Price | $143.45 | $44.00 |
| Market cap | $2.07B | $2.05B |
| Today | +7.93% | −0.32% |
| 1 month | +3.2% | +12.4% |
| 6 months | +17.2% | +87.6% |
| Year to date | +37.0% | +57.8% |
| 1 year | +103.7% | +94.5% |
| Revenue growth (YoY) | — | +22375.6% |
| Gross margin | — | 100.0% |
| Net margin | — | −48.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 20.8× |
| Net cash | $250.6M | $372.3M |
| Dividend yield | — | — |
| Volatility (60d) | 43.9% | 61.6% |
| Short % of float | 21.7% | 12.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).